Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Type Strain
no
Preceptrol®
no
Comments
Acapsular mutant
Medium
ATCC® Medium 28: Emmons' modification of Sabouraud's agar
Growth Conditions
Temperature: 26.0°C
Name of Depositor
ES Jacobson
References
Fromtling RA, et al. Decreased virulence in stable, acapsular mutants of cryptococcus neoformans. Mycopathologia 79: 23-29, 1982. PubMed: 6750405
Jacobson ES, Payne WR. UDP glucuronate decarboxylase and synthesis of capsular polysaccharide in Cryptococcus neoformans. J. Bacteriol. 152: 932-934, 1982. PubMed: 6752126
Still CN, Jacobson ES. Recombinational mapping of capsule mutations in Cryptococcus neoformans. J. Bacteriol. 156: 460-462, 1983. PubMed: 6352689
Jacobson ES, et al. Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans. J. Bacteriol. 150: 1292-1296, 1982. PubMed: 7042689
